Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,610 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I open-label trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study): study protocol.
Vatandoust S, Bright T, Roy AC, Watson D, Gan S, Bull J, Abbas MN, Karapetis CS. Vatandoust S, et al. Among authors: gan s. BMJ Open. 2019 May 5;9(5):e026732. doi: 10.1136/bmjopen-2018-026732. BMJ Open. 2019. PMID: 31061042 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 31804398
Responsiveness and convergent validity of QLU-C10D and EQ-5D-3L in assessing short-term quality of life following esophagectomy.
Bulamu NB, Vissapragada R, Chen G, Ratcliffe J, Mudge LA, Smithers BM, Isenring EA, Smith L, Jamieson GG, Watson DI; Australian Immunonutrition Study Group. Bulamu NB, et al. Health Qual Life Outcomes. 2021 Oct 2;19(1):233. doi: 10.1186/s12955-021-01867-w. Health Qual Life Outcomes. 2021. PMID: 34600554 Free PMC article. Clinical Trial.
Phase 1 trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study).
Vatandoust S, Bright T, Roy AC, Abbas MN, Watson DI, Gan S, Bull J, Sorich M, Scott-Hoy A, Luu LJ, Karapetis CS. Vatandoust S, et al. Among authors: gan s. Asia Pac J Clin Oncol. 2022 Aug;18(4):404-409. doi: 10.1111/ajco.13659. Epub 2021 Nov 23. Asia Pac J Clin Oncol. 2022. PMID: 34811896 Clinical Trial.
A Method for Increasing the Robustness of Stable Feature Selection for Biomarker Discovery in Molecular Medicine Developed Using Serum Small Extracellular Vesicle Associated miRNAs and the Barrett's Oesophagus Disease Spectrum.
Mayne GC, Woodman RJ, Watson DI, Bright T, Gan S, Lord RV, Bourke MJ, Levert-Mignon A, Bastian I, Irvine T, Schloithe A, Martin M, Sheehan-Hennessy L, Hussey DJ. Mayne GC, et al. Among authors: gan s. Int J Mol Sci. 2023 Apr 11;24(8):7068. doi: 10.3390/ijms24087068. Int J Mol Sci. 2023. PMID: 37108236 Free PMC article.
1,610 results